Cladribine (Pfizer Laboratories Div Pfizer Inc.)
Welcome to the PulseAid listing for the Cladribine drug offered from Pfizer Laboratories Div Pfizer Inc.. This Purine Antimetabolite [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc. |
| NON-PROPRIETARY NAME: | Cladribine |
| SUBSTANCE NAME: | CLADRIBINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Purine Antimetabolite [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2011-07-10 |
| END MARKETING DATE: | 0000-00-00 |
Cladribine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cladribine from Pfizer Laboratories Div Pfizer Inc. |
| LABELER NAME: | Pfizer Laboratories Div Pfizer Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/mL) |
| START MARKETING DATE: | 2011-07-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0069-0086_5a1b9efb-8d26-43a1-909b-d59ca0dc382a |
| PRODUCT NDC: | 0069-0086 |
| APPLICATION NUMBER: | ANDA200510 |
Other CLADRIBINE Pharmaceutical Manufacturers / Labelers:
